<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03320135</url>
  </required_header>
  <id_info>
    <org_study_id>UEPJMF ICT</org_study_id>
    <nct_id>NCT03320135</nct_id>
  </id_info>
  <brief_title>EMD for Treatment of Proximal Class-II Furcation Involvements</brief_title>
  <acronym>OFD</acronym>
  <official_title>Enamel Matriz Derivate for Treatment of Proximal Class II Furcation Defects: a Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidade Estadual Paulista Júlio de Mesquita Filho</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidade Estadual Paulista Júlio de Mesquita Filho</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the present study is to evaluate the clinical response of proximal furcations
      treated with enamel matrix derivative proteins (EMD).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Proximal class-II furcation represents a challeng to periodontal therapy. Studies show that
      the ultrasonic non-surgical therapy doesn't work in these defects and the guided tissue
      regeneration therapy with membranes also demonstrates an unpredictable improvement.
      Therefore, enamel matrix derivative proteins (EMD) have been proposed as a periodontal
      regenerative procedure due to their fundamental role in cementum development.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 20, 2017</start_date>
  <completion_date type="Anticipated">February 2019</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Horizontal clinical attachment level</measure>
    <time_frame>1 year</time_frame>
    <description>horizontal component of the defect</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Generalized Aggressive Periodontitis</condition>
  <arm_group>
    <arm_group_label>Enamel matrix derivative proteins</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Open flap debridement to enamel matrix derivative application in proximal class-II furcation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Open Flap Debridement</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Open flap debridement in proximal class-II furcation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Enamel matrix derivative proteins</intervention_name>
    <description>Open flap debridement to enamel matrix derivative to treat proximal furcation involvements.</description>
    <arm_group_label>Enamel matrix derivative proteins</arm_group_label>
    <other_name>Surgical therapy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Open Flap debridement</intervention_name>
    <description>Open flap debridement will be performed to decontaminate the proximal furcation involvements.</description>
    <arm_group_label>Enamel matrix derivative proteins</arm_group_label>
    <arm_group_label>Open Flap Debridement</arm_group_label>
    <other_name>Surgical therapy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of generalized aggressive periodontitis (Armitage, 1999; American Academy of
             Periodontology, 2015);

          -  Have undergone a first approach for periodontal treatment (full-mouth ultrasonic
             debridement);

          -  Presence of one proximal class-II furcation presenting probing depth &gt; 4 mm and
             bleeding on probing ;

          -  Good general health;

          -  Agree to participate in the study and sign the informed consent form (TCLE) after
             explaining the risks and benefits;

        Exclusion Criteria:

          -  Systemic problems (cardiovascular alterations, blood dyscrasias, immunodeficiency -
             ASA III / IV / V) that contraindicate the periodontal procedure;

          -  Have used antibiotics and anti-inflammatories in the last six months;

          -  Smoke ≥ 10 cigarettes/day;

          -  Pregnant or lactating;

          -  Chronic use of medications that may alter the response of periodontal tissues;

          -  Indication of antibiotic prophylaxis for dental procedures;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mauro M Santamaria, DDS, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Universidade Estadual Paulista &quot;Julio de Mesquita Filho&quot;, ICT/UNESP</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Naira RB Andere, DDS, MS</last_name>
    <phone>(11) 996308530</phone>
    <email>nairaandere@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mauro P Santamaria, DDS, PhD</last_name>
    <phone>(16) 981937777</phone>
    <email>mauro.santamaria@ict.unesp.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Naira Andere</name>
      <address>
        <city>São José dos Campos</city>
        <state>SP</state>
        <zip>12245010</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Naira RB Andere, DDS, MS</last_name>
      <phone>(11) 996308530</phone>
      <email>nairaandere@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Mauro P Santamaria, DDS, PhD</last_name>
      <phone>(16) 981937777</phone>
      <email>mauro.santamaria@ict.unesp.br</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <results_reference>
    <citation>Casarin RC, Del Peloso Ribeiro E, Nociti FH Jr, Sallum AW, Sallum EA, Ambrosano GM, Casati MZ. A double-blind randomized clinical evaluation of enamel matrix derivative proteins for the treatment of proximal class-II furcation involvements. J Clin Periodontol. 2008 May;35(5):429-37. doi: 10.1111/j.1600-051X.2008.01202.x. Epub 2008 Mar 12.</citation>
    <PMID>18341602</PMID>
  </results_reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 20, 2017</study_first_submitted>
  <study_first_submitted_qc>October 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 25, 2017</study_first_posted>
  <last_update_submitted>October 20, 2017</last_update_submitted>
  <last_update_submitted_qc>October 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidade Estadual Paulista Júlio de Mesquita Filho</investigator_affiliation>
    <investigator_full_name>Mauro Pedrine Santamaria</investigator_full_name>
    <investigator_title>DDS,MS,PhD</investigator_title>
  </responsible_party>
  <keyword>enamel matrix derivative</keyword>
  <keyword>proximal furcation</keyword>
  <keyword>randomized clinical trial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Aggressive Periodontitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Undecided.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

